,drug,MOAs
50,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,FLT3 inhibitor
6,COc1ccc(Cn2ccc3ccc(C(=O)NO)cc32)cc1,HDAC inhibitor
83,COc1cc(C=CC(=O)CC(=O)C=Cc2ccc(O)c(OC)c2)ccc1O,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor
36,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1,BCL inhibitor
47,CC1=CC(=O)c2ccccc2C1=O,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor
57,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor
74,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,insulin sensitizer|PPAR receptor agonist
3,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,ribonucleotide reductase inhibitor
102,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor
2,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C,glucocorticoid receptor antagonist|progesterone receptor antagonist
51,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,CDK inhibitor
1,CC(C=CC=C(C)/C=C/C1=C(C)CCCC1(C)C)=CC(=O)O,retinoid receptor agonist|retinoid receptor ligand
80,CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO,peptidase inhibitor
64,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,PLK inhibitor
38,Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1,dopamine uptake inhibitor
13,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,FLT3 inhibitor|JAK inhibitor
106,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor
40,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,IKK inhibitor
52,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,RNA synthesis inhibitor|topoisomerase inhibitor
24,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,dopamine receptor antagonist
39,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,HIV protease inhibitor
20,C=CCNC1=C2CC(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)C=CC=C(C)C(=O)NC(=CC1=O)C2=O,HSP inhibitor
67,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor
65,Cc1cc(C)c(N(Cc2ccccc2)S(=O)(=O)c2ccc(OCCNC(=O)c3cc4ccccc4o3)cc2)c(C(=O)NO)c1,metalloproteinase inhibitor
77,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,selective serotonin reuptake inhibitor (SSRI)
68,COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC,histone lysine methyltransferase inhibitor
99,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,proteasome inhibitor
95,CC(=O)NC1=NN(C(C)=O)C(C)(c2ccccc2)S1,kinesin-like spindle protein inhibitor
32,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,MEK inhibitor
94,Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor
69,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor
37,C=C1/C(=C\C=C2CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)C=C[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O,vitamin D receptor agonist
22,CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,ion channel antagonist
54,OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,adrenergic receptor agonist
73,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,IKK inhibitor|NFkB pathway inhibitor
45,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)C=C[C@H](O)CCC[C@@H](C)CC=C[C@H]3[C@@H]1O,microtubule inhibitor
49,NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O,nedd activating enzyme inhibitor
104,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,ALK tyrosine kinase receptor inhibitor
90,O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12,tyrosine kinase inhibitor
48,C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,Bruton's tyrosine kinase (BTK) inhibitor
9,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,RAF inhibitor
88,CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(=O)NO)CC(C)C,matrix metalloprotease inhibitor
28,Cn1cncc1[C@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,farnesyltransferase inhibitor
5,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator
53,Nc1nc(Nc2ccccc2)nc2c1ncn2C1OC(CO)C(O)C1O,adenosine receptor agonist
97,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,mTOR inhibitor
42,C=C1CC2C(CC[C@]3(C)C(=O)CCC23)[C@@]2(C)C=CC(=O)C=C12,aromatase inhibitor
81,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,T-type calcium channel blocker
56,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,cytochrome P450 inhibitor|imidazoline receptor ligand
70,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,src inhibitor
31,C[C@@H]1CC[C@H]2[C@@H](C)C(OC(=O)CCC(=O)O)OC3O[C@]4(C)CC[C@@H]1[C@]32OO4,DNA synthesis inhibitor
43,Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12,adenosine receptor antagonist
78,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|src inhibitor
34,CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1,laxative
61,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,FGFR inhibitor|VEGFR inhibitor
66,COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC,calcium channel blocker
25,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,dopamine receptor antagonist|serotonin receptor antagonist
15,Oc1c(Cl)cc(Cl)c2cccnc12,opioid receptor antagonist
103,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,mTOR inhibitor|PI3K inhibitor
46,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1,EGFR inhibitor
30,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,angiotensin receptor antagonist
55,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,VEGFR inhibitor
12,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor
93,O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1,Aurora kinase inhibitor|JAK inhibitor
60,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor
71,CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,HMGCR inhibitor
87,Cc1cc(C2CCCCC2)n(O)c(=O)c1,membrane integrity inhibitor
44,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,carnitine palmitoyltransferase inhibitor
18,O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,CHK inhibitor
79,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor
19,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,PI3K inhibitor
85,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,PARP inhibitor
11,O=C1Nc2ccccc2C1=C1Nc2ccccc2C1=NO,CDK inhibitor|glycogen synthase kinase inhibitor
33,CC/C(=C(\c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
58,CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1,p38 MAPK inhibitor
62,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor|tyrosine kinase inhibitor
82,Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1,glycogen synthase kinase inhibitor
75,CC12CCC3c4ccc(O)cc4CC(CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)C3C1CCC2O,estrogen receptor antagonist
4,OCc1ccc(-c2ccc(-c3ccc(CO)s3)o2)s1,MDM inhibitor
26,O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,topoisomerase inhibitor
59,CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)c1cn(C)c2ccccc12,tachykinin antagonist
98,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,phosphodiesterase inhibitor
14,CC(=Cc1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C,retinoid receptor agonist
92,O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12,PKA inhibitor
7,CC[C@@H](C(=O)C(C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)O)C1OC(CC)(C2CC[C@](O)(CC)[C@H](C)O2)C[C@@H]1C,bacterial permeability inducer
8,CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,calcineurin inhibitor
89,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,NFkB pathway inhibitor|proteasome inhibitor
63,CCC(C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](CC=C(C)[C@@H](OC3C[C@H](OC)C(O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)C=CC=C3CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,benzodiazepine receptor agonist
17,COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1,tubulin polymerization inhibitor
84,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,SYK inhibitor
27,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor
101,COc1c(C)c2c(c(O)c1CC=C(C)CCC(=O)O)C(=O)OC2,dehydrogenase inhibitor|inositol monophosphatase inhibitor
86,Clc1ccc(CON=C(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,bacterial cell wall synthesis inhibitor
41,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,Abl kinase inhibitor|Bcr-Abl kinase inhibitor
35,COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O,Aurora kinase inhibitor
72,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,KIT inhibitor|VEGFR inhibitor
23,Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1,thymidylate synthase inhibitor
76,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,AKT inhibitor
21,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,lanosterol demethylase inhibitor|sterol demethylase inhibitor
10,COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1OCCN(C)C,serotonin receptor antagonist
